Latest Healthcare Research Reports

Tag: asthma drugs market report

  • Asthma Drugs Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Asthma Drugs Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Asthma Drugs Market: What Growth Rate is Predicted?

    The size of the asthma drugs market has seen robust augmentation in the preceding years. The market size is projected to escalate from $23.05 billion in 2023 to $24.25 billion in 2024, growing at a compound annual growth rate (CAGR) of 5.2%. The expansion during the historical period can be credited to elements like environmental factors, a rise in respiratory disorders, shifts in lifestyle, and the advancement of healthcare infrastructure.

    The market size of asthma medication is projected to experience robust expansion in the upcoming years, reaching a projected $30 billion by 2028 with a compound annual growth rate (CAGR) of 5.5%. The predicted growth in the forecasted period can be accredited to the increasing levels of air pollution, an expanding elderly population, enhanced health consciousness, the emergence of personalized medicines, and advancements in biopharmaceuticals. The forecast period is also expected to observe major trends like small molecule therapies, home-oriented asthma care, therapies guided by biomarkers, therapeutic progress in serious asthma conditions, and partnerships for asthma study.

    Claim Your Free Sample of the Global Asthma Drugs Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp

    What Aspects Are Driving the Expansion of the asthma drugs Market?

    The growing number of asthmatic conditions is predicted to spur the expansion of the asthma drug market. Asthma is a chronic disorder that leads to inflammation and enlargement of the airways, which subsequently narrow the channels transporting air from the nose and mouth to the lungs. With the rising instances of asthma, there’s been a noticeable upsurge in the discovery of fresh asthma drugs for managing such conditions. For instance, as per the Centers for Disease Control and Prevention— a public health agency based in the US, the prevalence of Asthma in the US surged to 24,96 million in 2021 with 3,517 fatalities. Thus, the escalating count of asthmatic cases prompts an increase in the invention of innovative drugs, and this will continue to fuel the asthma drug market growth.

    What Are the Significant Segments of the Asthma Drugs Market?

    1) By Type Of Asthma: Allergic, Non-Allergic

    2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

    3) By Therapy: Preventive, Curative

    4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

    5) By End-User: Asthma Patients, COPD Patients

    What Trends Are Influencing the Evolution of the Asthma Drugs Market?

    The ongoing development of innovative products is a significant trend in the asthma medication market. Dominant companies in this market are committed to creating novel solutions to maintain their market standing. For example, in December 2021, American biopharmaceutical business, Amgen, and British biopharmaceutical enterprise, AstraZeneca, obtained FDA approval for their injectable asthma medication, Tezpire. This drug actively mitigates inflammation leading to asthmatic episodes and can potentially treat a broad spectrum of severe asthma patients, including those who have had no effective treatment alternatives before. Tezpire is the first and only biological drug shown to consistently decrease asthma-related symptoms in both Phase 2 and 3 clinical tests, which will result in an improved medicinal advantage for patients due to the increasing instance of asthma diagnosis.

    Order Now for Fast Delivery of Your Asthma Drugs Market Report!

    https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

    Which Geographic Areas Are Influencing the Growth of the Asthma Drugs Market?

    North America was the largest region in the asthma drugs market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Asthma Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the asthma drugs market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Asthma Drugs Market Include

    1. Asthma Drugs Market Executive Summary

    2. Asthma Drugs Market Segments

    3. Asthma Drugs Market Size And Template Market Growth Rate

    4. Key Asthma Drugs Market Trends

    5. Major Asthma Drugs Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Asthma Drugs Market

    26. Top Asthma Drugs Companies

    27. Asthma Drugs Market Opportunities And Strategies

    28. Asthma Drugs Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What’s The Growth Forecast For Asthma Drugs Market Through 2024-2033?

    What’s The Growth Forecast For Asthma Drugs Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The asthma drugs market has witnessed robust growth in recent years, indicating promising prospects for the future. With a compound annual growth rate (CAGR) of 5.2%, the market expanded from $23.05 billion in 2023 to $24.25 billion in 2024. This growth trajectory can be attributed to various environmental factors, increased respiratory disorders, lifestyle changes, and significant developments in healthcare infrastructure.

    Anticipating Future Growth

    Forecasts indicate a continued upward trajectory for the asthma drugs market. Predictions suggest that by 2028, the market will reach an impressive $30 billion, with a CAGR of 5.5%. Several factors contribute to this anticipated growth, including rising air pollution levels, an aging population, increasing healthcare awareness, trends in personalized medicine, and noteworthy biopharmaceutical innovations.

    Soaring Prevalence Of Asthmatic Disorders Propels Growth In The Asthma Drug Market

    The high prevalence of asthmatic disorders emerges as a significant driver propelling the growth of the asthma drug market. Asthma, characterized by inflammation and swelling of the airways, affects millions worldwide. The surge in asthma cases has led to increased efforts in identifying and developing new drugs to effectively manage this condition.

    • The US, as reported by the Centers for Disease Control and Prevention, witnessed a notable increase in asthma prevalence, with millions affected and thousands of deaths.
    • The rise in asthmatic disorders prompts the development of novel drugs, stimulating further market growth.

    View More On The Asthma Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

    Product Innovations Drive Market Evolution

    Innovations in product offerings play a pivotal role in shaping the asthma drug market landscape. Major players in the industry focus on developing advanced solutions to meet evolving patient needs and sustain their competitive edge. For instance, the FDA approval of Tezpire, an injectable drug developed by Amgen and AstraZeneca, marks a significant milestone in asthma treatment.

    • Tezpire effectively addresses inflammation underlying asthma attacks, offering hope for patients with severe asthma.
    • The approval of Tezpire reflects the industry’s commitment to delivering breakthrough solutions to combat respiratory disorders.

    Sandoz Expands Respiratory Portfolio Through Strategic Acquisition

    Strategic acquisitions contribute to the expansion and diversification of companies’ respiratory portfolios. In March 2022, Sandoz, a prominent pharmaceutical player, finalized the acquisition of Coalesce Product Development Limited. This move aligns with Sandoz’s objective of bolstering its position in the global respiratory market.

    • Coalesce Product Development brings a diverse portfolio of drug delivery devices, enhancing Sandoz’s capabilities in respiratory care.
    • The acquisition underscores the industry’s proactive approach to meeting evolving market demands through strategic partnerships.

    Segmentation Insights and Regional Outlook

    The asthma drugs market segmentation offers valuable insights into the diverse landscape of asthma treatment options and patient demographics. Segments include variations in asthma types, triggers, therapy approaches, drug classes, and end-users. Notably, North America emerged as the largest region in the asthma drugs market in 2023, with Asia Pacific poised for rapid growth in the forecast period.

    • Segmentation enables tailored approaches to asthma management, catering to specific patient needs and conditions.
    • The regional outlook highlights the dynamic nature of the asthma drugs market, with different regions experiencing varied growth trajectories.

    In conclusion, the asthma drugs market presents ample opportunities for growth and innovation. With an increasing focus on personalized medicine, technological advancements, and strategic collaborations, the industry is poised to address the evolving needs of patients worldwide. As stakeholders continue to navigate this dynamic landscape, a patient-centric approach remains paramount in driving positive outcomes and advancing respiratory healthcare globally.

    Request A Sample Of The Global Asthma Drugs Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=11924&type=smp